SauerR,BeckerH,HohenbergerW,C , Wittekind,C , Fietkau,R, 2004.Preoperative versus postoperative chemoradiotherapy for rectal cancer,N Engl J Med 351 1731e1740 -
SauerR,LierschT,MerkelS,FietkauR,HohenbergerW,HessC, 2012.Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years,J Clin Oncol 30 1926 -33
BossetJF,ColletteL,CalaisLG,MineurL,MaingonP,Radosevic-JelicL, 2006.Chemotherapy with preoperative radiotherapy in rectal cancer,N Engl J Med 355 1114e1123 -
StipaF,ChessinDB,ShiaJ,PatyPB,WeiserM,TempleLK, .A pathologic complete response of rectal cancer to preoperative combined modality therapy results in improved, -
5. DasP,SkibberJM,Rodriguez-BigasMA,FeigBW,ChangGJ,WolffRA, 2007.Predictors of tumor response and down staging in patients who receive preoperative chemoradiation for rectal cancer,Cancer 109 1750e1755 -
OnaitisMW,NooneRB,HartwigM,HurwitzH,MorseM,JowellP, 2001.Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience,Ann Surg 233 778 -85
MaasM,NelemansPJ,ValentiniV,DasP,RödelC,KuoLJ, 2010.Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data,Lancet Oncol 11 835 -44
WashingtonMK,BerlinJ,BrantonP,BurgartLJ,CarterDK,FitzgibbonsPL, 2009.Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum,Arch Pathol Lab Med 133 1539 -51
NagtegaalI,GasparC,MarijnenC,Van De VeldeC,FoddeR, 2004.Morphological changes in tumour type after radiotherapy are accompanied by changes in gene expression profile but not in clinical behaviour,J Pathol 204 183 -92
OokiA,AkagiK,YatsuokaT,AsayamaM,HaraH,YamamotoG, 2014.Inverse effect of mucinous component on survival in stage III colorectal cancer,J Surg Oncol 110 851 -7
ShiaJ,McManusM,GuillemJG,LeiboldT,ZhouQ,TangLH, 2011.Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy,Am J Surg Pathol 35 127 -34
CienfuegosJA,BaixauliJ,RotellarF,ArredondoJ,SolaJJ,ArbeaL, 2016.Clinical significance of cellular and acellular mucin pools in rectal carcinoma following preoperative chemoradiotherapy,Clin Transl Oncol 18 714 -21
BhattiAB,AkbarA,KhattakS,KazmiAS,JamshedA,SyedAA, 2014.Impact of acellular mucin pools on survival in patients with complete pathological response to neoadjuvant treatment in rectal cancer,Int J Surg 12 1123 -6
LimSB,HongSM,YuCS,HongYS,KimTW,ParkJH, 2013.Prevalence and clinical significance of acellular mucin in locally advanced rectal cancer patients showing pathologic complete response to preoperative chemoradiotherapy,Am J Surg Pathol 37 47 -52
de Campos-LobatoLF,DietzDW,StocchiL,VogelJD,LaveryIC,GoldblumJR, 2012.Clinical implications of acellular mucin pools in resected rectal cancer with pathological complete response to neoadjuvant chemoradiation,Colorectal Dis 14 62 -7
SmithKD,TanD,DasP,ChangGJ,KattepoguK,FeigBW, 2010.Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation,Ann Surg 251 261 -4
KangCM,LimSB,HongSM,YuCS,HongYS,KimTW, 2016.Prevalence and clinical significance of cellular and acellular mucin in patients with locally advanced mucinous rectal cancer who underwent preoperative chemoradiotherapy followed by radical surgery,Colorectal Dis 18 O10 -6
ShiaJ,GuillemJG,MooreHG, .Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome, -
2004.,Am J Surg Pathol 28 215 -23
BellucoC,De PaoliA,CanzonieriV,SigonR,FornasarigM,BuonadonnaA, 2011.Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies,Ann Surg Oncol 18 3686 -93
BittermanDS,Resende SalgadoL,MooreHG,SanfilippoNJ,GuP, 2015.Predictors of complete response and disease recurrence following chemoradiation for rectal cancer,Front Oncol 22 286 -
GurzuS,BaraT,BaraT,KadarZ,MolnarC,KovecsiA, 2014.Clinical significance of carcinoembryonic antigen expression of acellular mucin pools after preoperative chemoradiotherapy of rectal carcinoma,Cancer Biother Radiopharm 29 295 -7
RullierA,LaurentC,VendrelyV, 2005.Impact of colloid response on survival after preoperative radiotherapy in locally advanced rectal carcinoma,Am J Surg Pathol 29 602 -6
FrankelWL,JinM, 2015.Serosal surfaces, mucin pools, and deposits, oh my: challenges in staging colorectal carcinoma,Mod Pathol 28 S95 -108
WolthuisAM,PenninckxF,HaustermansK,De HertoghG,FieuwsS,Van CutsemE, 2012.Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome,Ann Surg Oncol 19 2833 -41
KaladyMF,de Campos-LobatoLF,StocchiL,KaladyMF,de Campos-LobatoLF,StocchiL, 2009.Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer,Ann Surg 250 582 -9
De Campos-LobatoLF,GeislerDP,da Luz MoreiraA,StocchiL,DietzD,KaladyMF, 2011.Neoadjuvant therapy for rectal cancer: the impact of longer interval between chemoradiation and surgery,J Gastrointest Surg 15 444 -50
AkbarA,BhattiAB,NiaziSK,SyedAA,KhattakS,RazaSH, 2016.Impact of time interval between chemoradiation and surgery on pathological complete response and survival in rectal cancer,Asian Pac J Cancer Prev 17 89 -93
BhattiAB,WaheedA,HafeezA,AkbarA,SyedAA,KhattakS, 2015.Can induction chemotherapy before concurrent chemoradiation impact circumferential resection margin positivity and survival in low rectal cancers?,Asian Pac J Cancer Prev 16 2993 -8
ChapuisPH,LinBP,ChanC,DentOF,BokeyEL, 2006.Risk factors for tumour present in a circumferential line of resection after excision of rectal cancer,Br J Surg 93 860 -5
den DulkM,MarijnenCA,PutterH, 2007.Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial,Ann Surg 246 83 -90
MarrR,BirbeckK,GarvicanJ,MacklinCP,TiffinNJ,ParsonsWJ, 2005.The modern abdominoperineal excision: the next challenge after total mesorectal excision,Ann Surg 242 740 -82
ShihabOC,BrownG,DanielsIR,HealdRJ,QuirkeP,MoranBJ, 2010.Patients with low rectal cancer treated by abdominoperineal excision have worse tumors and higher involved margin rates compared with patients treated by anterior resection,Dis Colon Rectum 53 53 -6